[ad_1] The logo of Swiss pharmaceutical group Lonza is seen at its headquarters in Basel, Switzerland March 2, 2020. REUTERS/Arnd Wiegmann (Reuters) – Moderna Inc and Swiss contract drugmaker Lonza…
Tag: Pharmaceuticals (NEC) (TRBC level 5)
Swiss boost COVID-19 vaccine reservations with shots from Pfizer, WHO-led programme
[ad_1] FILE PHOTO: Small bottles labelled with “Vaccine” stickers stand near a medical syringe in front of displayed “Coronavirus COVID-19” words in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File…
UPDATE 1-Italy ready to raise 2021 deficit to support businesses through Covid-19 – PM
[ad_1] (Adds quote, context) MILAN, Nov 11 (Reuters) – Italy’s government is ready to increase its 2021 budget deficit and review this year’s to fund further compensation for businesses hit…
Exclusive: EU seeks Moderna COVID vaccine deal at below $25 per dose – source
[ad_1] FILE PHOTO: Moderna’s logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration BRUSSELS (Reuters) – The European Commission wants…
Strong sterling knocks FTSE 100 despite trade lull
[ad_1] By Muvija M, Indranil Sarkar (Reuters) – London’s FTSE 100 slipped on Thursday as a surge in sterling pushed exporter stocks lower, missing out on a global rally led…
UPDATE 1-UK Stocks-Factors to watch on Jan 10
[ad_1] (Adds company news items and futures) Jan 10 (Reuters) – Britain’s FTSE 100 index is seen opening down 4 points on Wednesday, according to financial bookmakers, with futures down…
Expert Views: Pfizer ends COVID-19 trial with 95% efficacy
[ad_1] (Reuters) – Pfizer Inc said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine showed it was 95% effective, adding it had the required two-months…